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***List of acronyms***

DA - digastric muscle

MFT - myofunctional therapy

MM - masseter muscle

NPIS - numeric pain intensity scale

RMS - root mean square

SCM - sternocleidomastoid muscle

TA - anterior temporal muscle

TENS - transcutaneous electrical nerve stimulation

TMD - temporo-mandibular disorders

The altered neuromuscular behavior of the orofacial district known as facial hypertonia is a pathological clinical condition characterized by facial muscle tensive pains often associated with incorrect swallowing patterns that may result in temporo-mandibular disorders (TMD) or be the onset of episodes of jaw clenching or bruxism.^[@ref1]^ Clinical diagnosis is based on the examination of the electromyographic assesment of the jaw-closing muscles: the masseter, the digastric and sternocleidomastoid that have been seen to show an increase in their muscle tone when compared to their reference values, both in resting position and during specific postures.^[@ref6]^ The therapy usually involves a pharmacological approach in case of pyramidal hypertonia, relieving the disorder through muscle relaxants such as dantrolene, and through the use of plates and splints, transcutaneous electrical nerve stimulation (TENS) or other physical therapies. However, to date there isn't an univocal consent on the therapy that should be delivered.^[@ref9]^ Some authors have proposed myofunctional therapy (MFT) for the treatment of facial hypertonia, but there is no scientific consistent evidence showing the possibility of treating such painful condition exclusively through physiotherapic myofunctional treatment rehabilitation.^[@ref10],[@ref11],[@ref14]^ MFT is however universally accepted for the treatment of gnathological problems and orthodontics, but not for the treatment of myofacial pain and for the reduction of the episodes of jaw clenching and bruxism.^[@ref1],[@ref3],11\ 15^ Therefore, the aim of this study was to evaluate the effectiveness of MFT alone as treatment for facial hypertonia through clinical parameters and objective evaluation of electromyographic activity of the temporal, masseter, digastric and sternocleidomastoid muscles in patients suffering from chronic facial pain and bruxism.

Material and Methods {#sec1-1}
====================

Patients {#sec2-1}
--------

24 subjects, of which 9 males and 15 females age ranging between 25 and 45 years of age from the orthodontic and gnathology section of the Santa Chiara Hospital of Pisa, were treated with myofunctional therapy if at least one of the following conditions were present: facial pain, incorrect swallowing, clenching and hypertonia of the jaw muscles. If patients had been already treated with other physical manipulations, took drugs or medications or had orthodontical supports, they were excluded from investigation. Informed consent was provided to and signed by all participants according to the Helsinki Declaration.

Clinical Evaluation {#sec2-2}
-------------------

The painful subjective feeling of the facial pain of all subjects was assessed by a visual analogue scale, the numeric pain intensity scale (NPIS), characterized by a grading range between 0 and 10, where 0 indicates no pain and 10 worst possible pain, which was compiled before (T0) and 15 days after (T1) the completion of the MFT.^[@ref16],[@ref17]^ The clenching episodes were divided in relation to the physical discomfort reported by the subjects and by frequency per hour during the day. In particular, three categories were identified: low frequency (1-5 episodes/h); medium frequency (6-10 episodes/h) and high frequency (\>10 episodes/h). The number of clenching episodes were assessed through a questionnaire where each participant reported the number of clenching episodes that occurred during a period of 3 days and through audio sleep recordings for the evaluation of sleeping clenching episodes during a period of 3 days. The mean values of the 3 days was reported for analysis.

Electromyographic evaluation {#sec2-3}
----------------------------

Muscle facial hypertonia was assessed through surface electromyography (BioEMG™ of the Bio Research, Inc.) with the use of the BioPak 2.1iRC6 software, by detecting electromyographic activity of the following muscles: Right and left anterior temporal muscle (TA); right and left masseter muscles (MM); right and left sternocleidomastoid (SCM), and right and left digastric muscles (DA). Electromyographic recordings, each of which of the duration of 9 seconds, have been performed in two different jaw positions: 1) In resting position, holding the tip of the tongue in a physiological position (on the palatine spot), mouth closed with loose teeth and trying not to swallow nor touching the teeth with the tongue; 2) In a jaw clenching position for evaluation of voluntary muscle activity. The recorded signal was filtered through a band bass filter between 20 and 400Hz, the output signal was subsequently rectified and the root mean square (RMS) was taken into account for amplitude analysis. Mean bilateral muscle activity was taken into account for each muscle group of both sides. All recordings were performed before and after the standardized MFT Protocol described in "Myofunctional Therapy" of Daniel Garliner.^[@ref10]^

Statistics {#sec2-4}
----------

Statistical analysis was performed using Student\'s t-test for paired data and Wilcoxon test for nonparametric assessments. A p values \<0.05 was considered statistically significant. The STATISTICA software (StatSoft. Tulsa, ver.10) was used for all statistical analysis.

Results {#sec1-2}
=======

All subjects completed the MFT protocol for a period of 9 months. Facial pain, from the hypertonic muscles reduced significantly between T0 and T1 (NPIS: T0: 8.13±0:39 vs. T1: 2:43±1.75; p \<0.01). The mean value of the bruxism episodes during the daytime reported by the patients also reduced, passing from 6.75±0.92 at T0, to 1.05±2 at T1 (p\<0.01); in particular at T0 3 subjects reported a low frequency (1-5 episodes/h), 18 a medium frequency (5-10 episodes/h) and other 3 a high frequency (\>10 episodes/h). At T1 in 62.5% of cases the episodes of bruxism disappeared, in 12.5% a low frequency was reported and only in 25% of cases a medium bruxism frequency was present. No high frequency cases were reported after the MFT protocol ([Table 1](#table001){ref-type="table"}).

The tonic activity of the anterior temporal muscle, masseter, anterior digastric and sternocleidomastoid muscles bilaterally recorded in the resting position, showed a reduction in the mean amplitude, however such reduction was statistically significant from T0 to T1 only in the masseter muscle (T0: 1.88±0.31 μv vs. T1: 1.4±0.25 μv; p \<0.05) ([Table 2](#table002){ref-type="table"}).

Recordings of the anterior temporal, masseter and digastrics muscles during the voluntary activation tests showed in all cases clinical improvements characterized by the reduction of muscle activity after the completion of the MFT cycle, which was found to be statistically significant in the anterior temporal (T0: 167.9±19.6 μv vs. T1: 144.6±16:43 μv; p\<0.05) and anterior digastric muscles (T0: 58.97±8:38 μv vs. T1: 52.79±7:44 μv; p\<0.05) ([Table 3](#table003){ref-type="table"}).

The differences in absolute values between the activation of each of the right and left muscle groups performed at T0 and T1 during clenching and swallowing showed a tendency towards symmetry after MFT for all muscle groups, with a significant improvement in relation to the masseter muscles (p\<0.05) ([Table 4](#table004){ref-type="table"}).

Discussion {#sec1-3}
==========

Myofunctional therapy, has been studied by various authors in order to solve problems and painful conditions regarding dentistry and gnathology. Some studies show that, MFT has been applied and compared with the use of splints, resulting more effective than the latter for the treatment of temporomandibular joint disorders^[@ref11],\ [@ref15],\ [@ref18]^; other authors have observed that MFT can affect perioral muscles balancing their activity^[@ref19],\ [@ref20]^. To date positive results have also been highlighted in the use of MFT for the resolution of otologic problems,^[@ref21]^ typical and atypical swallowing problems in infants^[@ref22]^ and as main supportive therapy to prevent relapses after orthodontic treatment.^[@ref3]^

Our work seems to indicate that myofunctional therapy can be used alone as a treatment strategy to reduce facial pain, episodes of clenching and facial hypertonic muscle imbalances. The analysis of pain perception according to the NPIS, has clear clinical significance. The improvement resulting from the myofunctional therapy has also a psychological impact in patients with chronic pain; the significant reduction of pain with which these patients have long lived with, is a definite clinical outcome. In addition, the American Academy of Oro-facial pain, has stated that 50% of the causes thet may lead to facial pain is caused by muscle hypertonia^[@ref23]^ and therefore the reduction of the NPIS score after MFT proves that it is possible to reduce or eliminate painful episodes exclusively through physical therapy.^[@ref4],[@ref24]^

The electromyographic results at T0 and T1 has also enabled us to draw some encouraging conclusions. Despite the limited number of patients, the automatization of the tongue's posture on the palatine spot and the swallowing function, obtained by the MFT appears to have yielded significant results in regard to the reduction of the bilateral activity of the masseter muscles during the resting position and a better activation pattern during the voluntary jaw serration. Since the masseters are the main muscles involved during the episodes of bruxism,^[@ref25]^ a reduction of their resting activity combined with the reduction of the number of bruxism episodes per day indicates the effectiveness of the MTF for the treatment of bruxism and involuntary jaw clenching. Other interesting conclusion may be drawn by the results obtained during the voluntary clenching tasks; the bilateral electromyographic activity of the digastrics muscles significantly decreased after the MFT and a better balance between the right and left muscle was obtained. MFT could also be used as a viable therapy for muscle tensive headaches, neck pain, and for prevention of TMJ disorders^1\ 26,[@ref27]^. In conclusion, this study showed that MFT can be an effective therapeutic strategy in regard to the treatment of muscle facial pain and hypertonia of the chewing and swallowing muscles. All treated patients had a reduction of facial pain and reduced the number of bruxism episodes per hour, and in many cases such episode disappeared. MFT combined with electromyographic assessment may be effective to evaluate and balance muscle asymmetries that could result in facial pain.

No funding was used for the realization of the manuscript.

###### 

Number of daily bruxism episodes in the analyzed cohort

  N° of episodes   T0 N (%)   T1 N (%)
  ---------------- ---------- -----------
  0                0 (-)      15 (62.5)
  1-5 / hour       3 (12.5)   3 (12.5)
  5-10 / hour      18(75)     6(25)
  \> 10 / hour     3 (12.5)   0 (-)

###### 

Tonic activity of anterior temporal, masseter, sternocleidomastoid and digastric muscles

  Muscle group               Parameter   Registration interval   *P*           
  -------------------------- ----------- ----------------------- ------------- ------
                                         T0                      T1            
  Anterior temporal(μV)      Mean        2.67 ± 0.56             2.09 ± 0.26   Ns
  Masseter(μV)               Mean        1.88 ± 0.31             1.4 ± 0.25    0.04
  Sternocleidomastoide(μV)   Mean        2.19 ± 0.77             1.5 ± 0.16    Ns
  Anterior Digastric (μV)    Mean        2.29 ± 0.31             2.53 ± 0.72   Ns

Ns: Not significant

###### 

Electric activity of the anterior temporal muscles, the masseter muscles and the anterior digastrics muscles during bruxism episodes

  Muscle group              Parameter   Registration interval   *P*              
  ------------------------- ----------- ----------------------- ---------------- -------
                                        T0                      T1               
  Anterior Temporal(μV)     Mean        167.9 ± 19.6            144.6 ± 16.43    0.049
  Masseter(μV)              Mean        117.48 ± 20.89          112.79 ± 27.88   Ns
  Anterior Digastric (μV)   Mean        58.97 ± 8.82            52.79 ± 7.44     0.03

Ns: *Not Significant*

###### 

Absolute difference between right and left muscles

  Muscle group              Parameter   Registration interval   *P*            
  ------------------------- ----------- ----------------------- -------------- ------
                                        T0                      T1             
  Anterior Temporal(μV)     \|Δ\|       70.86 ± 14.19           43.95 ± 5.72   Ns
  Masseter(μV)              \|Δ\|       36.83 ± 9.23            20.46 ± 8.52   0.04
  Anterior Digastric (μV)   \|Δ\|       13.11 ± 4.17            6.50 ± 3.18    Ns

Ns: *Not significant*
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